Vimarsana
Biggest News Aggregation in the World

Page 2 - Jay Luly News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jay Luly. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jay Luly Today - Breaking & Trending Today

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q2 2023 Earnings Call Transcript - Vimarsana News

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q2 2023 Earnings Call Transcript

Operator: Good afternoon, and welcome to Enanta Pharmaceuticals Fiscal Second Quarter Ended March 31, 2022 Financial Results Conference Call. At this time, all participants are in a listen only mode.

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q1 2023 Earnings Call Transcript - Vimarsana News

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q1 2023 Earnings Call Transcript

Operator: Good afternoon, and welcome to Enanta Pharmaceuticals Fiscal First Quarter Ended December 31, 2022 Financial Results Conference Call. At this time all participants are in a listen only mode.

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q4 2022 Earnings Call Transcript - Vimarsana News

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q4 2022 Earnings Call Transcript

Operator: Good afternoon, and welcome to Enanta Pharmaceuticals Fiscal Fourth Quarter and Full Year Ended September 30, 2022 Financial Results Conference Call.

Enanta Pharmaceuticals (ENTA) Q3 2022 Earnings Call Transcript - Vimarsana News

Enanta Pharmaceuticals (ENTA) Q3 2022 Earnings Call Transcript

ENTA earnings call for the period ending June 30, 2022.

Source: fool.com
Enanta Pharmaceuticals Appoints Scott T. Rottinghaus, M.D., as Senior Vice President and Chief Medical Officer - Vimarsana News

Enanta Pharmaceuticals Appoints Scott T. Rottinghaus, M.D., as Senior Vice President and Chief Medical Officer

Enanta Pharmaceuticals, Inc. , a clinical-stage biotechnology company dedicated to creating novel, small molecule drugs for viral infections and liver diseases, today announced the appointment of... | August 8, 2022